TIAA CREF Investment Management’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-28,093	Closed	-$982K	–	3086
2018 Q1	$982K	Sell	28,093 -15,342	-35%	-$594K	﹤0.01%	2455
2017 Q4	$1.85M	Buy	43,435 +18,228	+72%	+$781K	﹤0.01%	2182
2017 Q3	$1.08M	Buy	25,207 +4,241	+20%	+$159K	﹤0.01%	2477
2017 Q2	$777K	Buy	20,966 +3,861	+23%	+$171K	﹤0.01%	2667
2017 Q1	$926K	Sell	17,105 -1,436	-8%	-$74.8K	﹤0.01%	2545
2016 Q4	$985K	Sell	18,541 -786	-4%	-$44.7K	﹤0.01%	2545
2016 Q3	$1.17K	Sell	19,327 -7,446	-28%	-$464K	﹤0.01%	2463
2016 Q2	$1.76M	Buy	26,773 +3,046	+13%	+$193K	﹤0.01%	2203
2016 Q1	$1.34M	Sell	23,727 -652	-3%	-$73.4K	﹤0.01%	2306
2015 Q4	$5.73M	Sell	24,379 -894	-4%	-$195K	﹤0.01%	1472
2015 Q3	$4M	Sell	25,273 -758	-3%	-$215K	﹤0.01%	1695
2015 Q2	$9.85M	Buy	26,031 +396	+2%	+$157K	0.01%	1156
2015 Q1	$10.7M	Buy	25,635 +810	+3%	+$290K	0.01%	1094
2014 Q4	$6.8M	Sell	24,825 -1,057	-4%	-$263K	﹤0.01%	1404
2014 Q3	$5.03M	Sell	25,882 -787	-3%	-$171K	﹤0.01%	1615
2014 Q2	$6.53M	Buy	26,669 +922	+4%	+$208K	﹤0.01%	1478
2014 Q1	$6.82M	Sell	25,747 -389	-1%	-$149K	﹤0.01%	1387
2013 Q4	$9.49M	Buy	26,136 +1,048	+4%	+$404K	0.01%	1185
2013 Q3	$13.3M	Sell	25,088 -751	-3%	-$258K	0.01%	930
2013 Q2	$6.05M	Buy	+25,839	New	+$5.09M	﹤0.01%	1390